SUBOXONE-1 | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

SUBOXONE-1
US Exclusivities

PharmaCompass Sponsored Ads

Contact Supplier

Naloxone Hydrochloride

Contact Supplier

pharmacompass-1-m-2026-01-12

PharmaCompass Sponsored Ads

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

pharmacompass-2-2026-02-09

SUBOXONE-1

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 13 USDMF, 11 CEP/COS, 1 JDMF, 3 EU WC, 3 KDMF, 18 NDC API, 17 Listed Suppliers, $ API Reference Price

39 API Suppliers
13 USDMF
11 CEP/COS
1 JDMF
3 EU WC
3 KDMF
18 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

94 Drugs in Development

94 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

695 FDF Dossiers, 173 FDA Orange Book, 409 Europe, 19 Canada, 52 Australia, 11 South Africa, 31 Listed Dossiers

695 FDF Dossiers
173 FDA Orange Book
409 Europe
19 Canada
52 Australia
11 South Africa
31 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE, FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE, FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.4MG/0.4ML (0.4MG/0.4ML), TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 2MG/0.4ML (2MG/0.4ML), FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE
FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE
FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.4MG/0.4ML (0.4MG/0.4ML)
TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 2MG/0.4ML (2MG/0.4ML)
FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 4 Rochem International Inc, 18 SPI Pharma, 1 Pharm-RX Chemical, 3 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 4 Kirsch Pharma, 1 Panvo Organics, 1 ACG Worldwide, 10 Actylis, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 16 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 7 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 24 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 1 Symrise, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 40 Coating Systems & Additives, 37 Direct Compression, 28 Granulation, 27 Taste Masking, 24 Thickeners and Stabilizers, 22 Disintegrants & Superdisintegrants, 20 Chewable & Orodispersible Aids, 19 Controlled & Modified Release, 19 Lubricants & Glidants, 14 Co-Processed Excipients, 13 Parenteral, 10 Topical, 9 Solubilizers, 6 Film Formers & Plasticizers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 3 Rheology Modifiers, 3 Emulsifying Agents, 2 Coloring Agents, 1 Surfactant & Foaming Agents

65 Fillers, Diluents & Binders
40 Coating Systems & Additives
37 Direct Compression
28 Granulation
27 Taste Masking
24 Thickeners and Stabilizers
22 Disintegrants & Superdisintegrants
20 Chewable & Orodispersible Aids
19 Controlled & Modified Release
19 Lubricants & Glidants
14 Co-Processed Excipients
13 Parenteral
10 Topical
9 Solubilizers
6 Film Formers & Plasticizers
5 Empty Capsules
5 API Stability Enhancers
4 Vegetarian Capsules
3 Rheology Modifiers
3 Emulsifying Agents
2 Coloring Agents
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 261 News #PharmaBuzz

1 Data Compilation #PharmaFlow
261 News #PharmaBuzz

GLOBAL SALES INFORMATION

37 US Medicaid Prescriptions, 37 Regulatory FDF Prices

37 US Medicaid Prescriptions
37 Regulatory FDF Prices

MARKET PLACE

21 APIs, 10 FDF Dossiers

21 APIs
10 FDF Dossiers

PATENTS & EXCLUSIVITIES

149 US Patents, 2 US Exclusivities, 27 Health Canada Patents

149 US Patents
2 US Exclusivities
27 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 7 Others

3 EDQM
7 Others

$ API Ref.Price (USD/KG) : 10,323 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

2 All

01 1AMPHASTAR PHARMS INC

02 1SCIENTURE

filter Product Reset all filters

2 All

01 2NALOXONE HYDROCHLORIDE

filter Exclusivity Expiration Date Reset all filters

2 All

01 12026-03-07

02 12027-04-19

filter Exclusivity Code Reset all filters

2 All

01 2NP

Veranova Naloxone hydrochloride

Product Main Page

SCIENTURE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

NALOXONE HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2027-04-19

Application Number

215487

Product Number

1

Exclusivity Details

01

SCIENTURE

NALOXONE HYDROCHLORIDE

International Sweetener Colloquium

Not Confirmed

SCIENTURE

U.S.A

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

NALOXONE HYDROCHLORIDE

Exclusivity Code : NP

Exclusivity Expiration Date : 2027-04-19

Application Number : 215487

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

AMPHASTAR PHARMS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

NALOXONE HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2026-03-07

Application Number

208969

Product Number

1

Exclusivity Details

02

AMPHASTAR PHARMS INC

NALOXONE HYDROCHLORIDE

International Sweetener Colloquium

Not Confirmed

AMPHASTAR PHARMS INC

U.S.A

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

NALOXONE HYDROCHLORIDE

Exclusivity Code : NP

Exclusivity Expiration Date : 2026-03-07

Application Number : 208969

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.